349 related articles for article (PubMed ID: 30351218)
1. Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient.
Besemer AE; Grudzinski JJ; Weichert JP; Hall LT; Bednarz BP
Cancer Biother Radiopharm; 2019 Feb; 34(1):13-23. PubMed ID: 30351218
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Pharmacokinetics and Dosimetry Studies of
Marsh IR; Grudzinski J; Baiu DC; Besemer A; Hernandez R; Jeffery JJ; Weichert JP; Otto M; Bednarz BP
J Nucl Med; 2019 Oct; 60(10):1414-1420. PubMed ID: 30926646
[TBL] [Abstract][Full Text] [Related]
3. CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer.
Grudzinski J; Marsh I; Titz B; Jeffery J; Longino M; Kozak K; Lange K; Larrabee J; Weichmann A; Moser A; Bednarz B
Cancer Biother Radiopharm; 2018 Apr; 33(3):87-95. PubMed ID: 29641256
[TBL] [Abstract][Full Text] [Related]
4. Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques.
Grimes J; Celler A
Med Phys; 2014 Sep; 41(9):092501. PubMed ID: 25186410
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform.
Besemer AE; Yang YM; Grudzinski JJ; Hall LT; Bednarz BP
Cancer Biother Radiopharm; 2018 May; 33(4):155-165. PubMed ID: 29694246
[TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation of a Three-Dimensional Internal Dosimetry Technique for Liver Radioembolization with
Plachouris D; Mountris KA; Papadimitroulas P; Spyridonidis T; Katsanos K; Apostolopoulos D; Papathanasiou N; Hazle JD; Visvikis D; Kagadis GC
Cancer Biother Radiopharm; 2021 Dec; 36(10):809-819. PubMed ID: 33656372
[No Abstract] [Full Text] [Related]
7. Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.
Plyku D; Loeb DM; Prideaux AR; Baechler S; Wahl RL; Sgouros G; Hobbs RF
Cancer Biother Radiopharm; 2015 Nov; 30(9):369-79. PubMed ID: 26560193
[TBL] [Abstract][Full Text] [Related]
8. Simplified image-based dosimetry using planar images and patient-specific S-values.
Kim KM; Suh M; Cheon GJ; Lee MS; Lee JS
Med Phys; 2024 Feb; ():. PubMed ID: 38340367
[TBL] [Abstract][Full Text] [Related]
9. Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404.
Besemer AE; Titz B; Grudzinski JJ; Weichert JP; Kuo JS; Robins HI; Hall LT; Bednarz BP
Phys Med Biol; 2017 Jul; 62(15):6008-6025. PubMed ID: 28682793
[TBL] [Abstract][Full Text] [Related]
10. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in
Plyku D; Hobbs RF; Huang K; Atkins F; Garcia C; Sgouros G; Van Nostrand D
J Nucl Med; 2017 Jul; 58(7):1146-1154. PubMed ID: 28104741
[TBL] [Abstract][Full Text] [Related]
12. Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.
Huang SY; Bolch WE; Lee C; Van Brocklin HF; Pampaloni MH; Hawkins RA; Sznewajs A; DuBois SG; Matthay KK; Seo Y
Mol Imaging Biol; 2015 Apr; 17(2):284-94. PubMed ID: 25145966
[TBL] [Abstract][Full Text] [Related]
13. Comparison of voxel S-value methods for personalized voxel-based dosimetry of
Kim KM; Lee MS; Suh MS; Selvam HSMS; Tan TH; Cheon GJ; Kang KW; Lee JS
Med Phys; 2022 Mar; 49(3):1888-1901. PubMed ID: 35014699
[TBL] [Abstract][Full Text] [Related]
14. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
15. VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4.
Kost SD; Dewaraja YK; Abramson RG; Stabin MG
Cancer Biother Radiopharm; 2015 Feb; 30(1):16-26. PubMed ID: 25594357
[TBL] [Abstract][Full Text] [Related]
16. Combined model-based and patient-specific dosimetry for
Plyku D; Mena E; Rowe SP; Lodge MA; Szabo Z; Cho SY; Pomper MG; Sgouros G; Hobbs RF
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):989-998. PubMed ID: 29460025
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of two dosimetry software programs for
Ramonaheng K; van Staden JA; du Raan H
Heliyon; 2022 Jul; 8(7):e09830. PubMed ID: 35865988
[TBL] [Abstract][Full Text] [Related]
18. Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.
Sgouros G; Squeri S; Ballangrud AM; Kolbert KS; Teitcher JB; Panageas KS; Finn RD; Divgi CR; Larson SM; Zelenetz AD
J Nucl Med; 2003 Feb; 44(2):260-8. PubMed ID: 12571219
[TBL] [Abstract][Full Text] [Related]
19. Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.
Quinn BM; Gao Y; Mahmood U; Pandit-Taskar N; Behr G; Zanzonico P; Dauer LT
BMC Med Imaging; 2020 Jan; 20(1):9. PubMed ID: 31996149
[TBL] [Abstract][Full Text] [Related]
20. A pilot study on the feasibility of real-time calculation of three-dimensional dose distribution for (153)Sm-EDTMP radionuclide therapy based on the voxel S-values.
Feng G; Lixin C; Xiaowei L; Tsao SY; Weiguang Z; Wei F
Cancer Biother Radiopharm; 2010 Jun; 25(3):345-52. PubMed ID: 20578840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
